InvestorsHub Logo
Followers 55
Posts 6415
Boards Moderated 1
Alias Born 07/28/2015

Re: None

Thursday, 09/15/2022 1:06:30 PM

Thursday, September 15, 2022 1:06:30 PM

Post# of 113741
Steve Slilaty sold Advanomics Corp for allegedly around $1B or something like that while the stock price and market cap was very high.

However, I believe he only walked away with a bit of cash and the worthless adva-27a patent that he was able to get the Canadian auditing firm (mnp.ca — The Mpact CPA) to value Sunshine at around $1,000,000,000 ($1 billion)

All he had to do was submit the correct paperwork that said adva27a was worth an estimated billion bucks and perhaps his ownership and sale of Advanomics, and I believe they owned a pharmaceutical manufacturing plant that they used along with other contracts that fell through to get such a high valuation. Then they sold the pharmaceutical plant right back to the same owner.

I think this is how all this unfolded to mislead investors into thinking a worthless company was worth at least around $1B which paved the path to where it is today.

MPN audited the documents and paperwork that was submitted, but they don’t have to verify the accuracy. There is a HUGE problem here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News